Home NDC 67751-151 Zantac 150
Product NDC 67751-151
11-digit product format 677510151
Labeler code 67751
Product ID 67751-151_97df45bd-27c6-2fc1-e053-2a95a90a8792
Type HUMAN OTC DRUG
Nonproprietary name RANITIDINE
Dosage form TABLET, COATED
Route ORAL
Labeler Navajo Manufacturing Company Inc.
Application NDA021698
Marketing category NDA
Marketing start 2016-09-16
Marketing end 0000-00-00
Substance RANITIDINE HYDROCHLORIDE
Active strength 150 mg/1
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 67751-151-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 67751-151-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 67751-151-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 67751-151-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 67751-151-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 67751-151-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 67751-151-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 67751-151-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 67751-151-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 67751-151-01 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 67751-151-01 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 67751-151-01 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021698-001 ZANTAC 150 RANITIDINE HYDROCHLORIDE EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 N021698-002 ZANTAC 150 RANITIDINE HYDROCHLORIDE EQ 150MG BASE TABLET / ORAL RLD 2007-03-13
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-04-04 05:41 UTC 2022-04 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD, RS 2004-08-31 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021698-001 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2004-08-31 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N021698-002 ZANTAC 150 EQ 150MG BASE TABLET / ORAL RLD 2007-03-13 3bdfa0b2c4d7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67751-151-01 67751015101 1 POUCH in 1 CARTON (67751-151-01) > 1 TABLET, COATED in 1 POUCH 1 pouch 2016-09-16 0000-00-00 No No Current